Signaling Pathways - Eukaryotic elongation factors - Aurora Kinases - Hydroxylases - Vitamin D receptors (VDRs)
清除全部
- A8711 DDD1074982 CitationTarget: Eukaryotic elongation factorsSummary: 新型的多级抗疟疾制剂
- A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3抑制剂
- B4751 L-MimosineTarget: HydroxylasesSummary: 铁螯合剂和脯氨酰-4-羟化酶抑制剂
- B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式
- B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂
- A8807 MK-8745Target: Aurora KinasesSummary: Aurora A的强效选择性抑制剂。
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A4489 TC-A 2317 hydrochlorideTarget: Aurora KinasesSummary: Aurora kinase A抑制剂
- A3760 Reversine中文名: 逆转素Target: Aurora KinasesSummary: Aurora激酶抑制剂
- A3396 ErcalcitriolTarget: Vitamin D receptors (VDRs)Summary: 维生素D2的活性代谢物